Anthrax is a severe infectious disease caused by the bacterium Bacillus anthracis. It can be contracted by coming into contact with infected animals or animal products, with the bacteria entering the body through inhalation, ingestion, or skin wounds. Once inside, the spores can germinate and release toxins, resulting in potentially severe and fatal respiratory and gastrointestinal issues.
This research study is evaluating the safety and immune response of an investigational vaccine administered at two dose levels on two vaccination schedules, including a primary series and booster doses against Anthrax disease.
The study may be an option if you:
Are aged 18-65 years old.
Are in good health and have no unstable medical condition.
Have had no history of Anthrax disease or exposure to Anthrax.
Have had no previous vaccination with any Anthrax vaccine.
Other criteria apply.
This research study will include 15 scheduled visits to the clinic site and 7 phone calls. Qualified participants may receive the investigational vaccine and study-related evaluations and care at no cost. Financial compensation may also be provided for time and travel expenses. You will receive $100-150 for each completed study visit and $25 for any unscheduled completed visits that may occur.
Visit our website for more details: https://www.accellacare.us/join-a-study/vaccines/anthrax-vaccine